Dupilumab for Aspirin-exacerbated Respiratory Disease
Clinical trial NCT03595488 · COMPLETED
Trial details
- NCT number
- NCT03595488
- Sponsor
- Rochester General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2019-12-11
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.